| Literature DB >> 35232472 |
Chengquan Tan1, Zihao Huang1, Wenyu Xiong1, Hongxuan Ye1, Jinping Deng2, Yulong Yin3.
Abstract
The fertility of sows mainly depends on the embryo losses during gestation and the survival rate of the post-farrowing piglets. The selection of highly-prolific sows has been mainly focused on the selection of genotypes with high ovulatory quota. However, in the early- and post-implantation stages, the rate of embryo losses was increased with the increase of zygotes. Among the various factors, placental growth and development is the vital determinant for fetal survival, growth, and development. Despite the potential survival of fetuses with deficient placental development, their life-conditions and growth can be damaged by a process termed intrauterine growth retardation (IUGR). The newborn piglets affected by IUGR are prone to increased morbidity and mortality rates; meanwhile, the growth, health and welfare of the surviving piglets will remain hampered by these conditions, with a tendency to exacerbate with age. Functional amino acids such as glycine, proline, and arginine continue to increase with the development of placenta, which are not only essential to placental growth (including vascular growth) and development, but can also be used as substrates for the production of glutathione, polyamines and nitric oxide to benefit placental function in many ways. However, the exact regulation mechanism of these amino acids in placental function has not yet been clarified. In this review, we provide evidence from literature and our own work for the role and mechanism of dietary functional amino acids during pregnancy in regulating the placental functional response to fetal loss and birth weight of piglets. This review will provide novel insights into the response of nutritionally nonessential amino acids (glycine and proline) to placental development as well as feasible strategies to enhance the fertility of sows.Entities:
Keywords: Amino acids; Birth weight; Fetal loss; Pigs; Placenta
Year: 2022 PMID: 35232472 PMCID: PMC8889744 DOI: 10.1186/s40104-022-00676-5
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Fig. 1Porcine placental barrier and conceptus. Representations of the placental barrier in swine (A) and conceptus within the uterine horn (B). Note that the allantois also supports the vascular elements of the epitheliochorial placenta of the pig. The amnion is filled with amniotic fluid that facilitates the embryo/fetus to allow it to develop symmetrically and not adhere to other tissues
Fig. 2Synthesis of polyamines from proline and their function in the porcine placenta. Unlike most other tissues, which convert arginine to polyamines via arginase and ornithine decarboxylase, the porcine placenta lacks arginase activity, so it cannot synthesize ornithine from arginine. Degradation of ODC is regulated via OAZ, which binds to ODC, while AZIN, a protein with a similar structure to ODC but with no activity, can bind to OAZ with a higher affinity, thus preventing ODC degradation. Note that there are three isoforms of OAZ (OAZ1, OAZ2 and OAZ3) and two isoforms of AZIN (AZIN1 and AZIN2). DFMO is a catalytic, irreversible inhibitor of ODC. For porcine placentae, polyamines mainly have roles in angiogenesis, oxidative stress, protein synthesis, and apoptosis. Solid black arrows indicate direct activation, and dashed black arrows indicate indirect activation. ADC, arginine decarboxylase; α-KG, α-ketoglutarate; AZIN, antizyme inhibitor; DCAM, decarboxylated S-adenosylmethionine; DFMO, difluoromethylornithine; MTA, methylthioadenosine; mTOR, mechanistic target of rapamycin; OAT, ornithine aminotransferase; OAZ, antizyme; ODC, ornithine decarboxylase; P-5-C,△1-L-Pyrroline-5-Carboxylate; POX, proline oxidase; PPi, inorganic pyrophosphate; ROS, reactive oxygen species; SAM, S-adenosylmethionine; SAMD, S-adenosylmethionine decarboxylase; SAMS, S-adenosylmethionine synthase
Summary of relevant reports on the effects of maternal dietary arginine supplementation on the reproductive performance in swine in the last decade
| Supple-mentation period | Arginine content in basal diet, % | Supple-mental arginine, % | Litter size of live-born piglets | Litter weight of live-born piglets | Placental weight | References |
|---|---|---|---|---|---|---|
| d 14–25 | 0.70% | 0.4% | ↑by 2.2 per litter | – | ↑by 34% | [ |
| d 14–25 | 0.70% | 0.8% | ↑by 1.7 per litter | – | ↑by 21% | [ |
| d 14–28 | 1.07% | 0.87% | ↑by 3.7 per litter | ↑by 32% | – | [ |
| d 1–114 | 0.72% | 0.25% | ↑by 0.8 per litter | – | – | [ |
| d 22–114 | 0.88% | 0.83% | ↑by 1.1 per litter | ↑by 11% | ↑by 16% | [ |
| d 30–90 or d 30–114 | 0.73% | 1% | ↑by 1.6 per litter | ↑ | Un | [ |
| d 30–110 | 0.61% | 0.1% | ↑by 1.1 per litter | – | – | [ |
| d 70–110 | 0.72% | 0.28% | ↑by 1.2 per litter | – | – | [ |
| d 70–110 | 0.72% | 0.78% | ↑by 1.1 per litter | ↑by 12% | – | [ |
| d 85–114 | Un | 1% | ↑by 1.4 per litter | – | Un | [ |
| d 90–114 | Un | 1% | – | ↑by 16% | Un | [ |
Un, undetermined; ↑, increase; —, no effect
Fig. 3The L-arginine-NO biosynthetic pathway regulates key vasculogenic and angiogenic factors in endothelial cells and vascular smooth muscle cells in the placenta. Arginine stimulates placental NO synthesis mainly by enhancing the generation of BH4, an essential cofactor for NOSs. Estrogen and progesterone augmented the constitutive and inducible NOS activities and the BH4 concentration in the porcine placenta, thus playing synergetic roles in promoting the placental NO synthesis. The porcine placenta lacks arginase and arginine decarboxylase and thus cannot synthesize ornithine from arginine. NO interacts with critical mediators of angiogenesis (VEGF, PIGF, and the angiopoietins). The induction of angiogenesis by angiopoietin and VEGF proteins is dependent on the amount of VEGF and Ang-1/Ang-2 in endothelial cells. Besides, NO diffuses to the underlying VSMCs where they act on GTP to produce cGMP via guanylate cyclase, which is capable of dilating blood vessels. Ang-1/Ang-2, angiopoietin-1 and angiopoietin-2; BH4, tetrahydrobiopterin; cGMP, cyclic guanosine monophosphate; eNOS, endothelia nitric oxide synthase; Flt-1, fms-like tyrosine kinase-1; GTP, guanosine; mTOR, mechanistic target of rapamycin; NADP+, nicotinamide adenine dinucleotide phosphate; NADPH, nicotinamide adenine dinucleotide phosphate hydrogen; NO, nitric oxide; NOS, nitric oxide synthase; PIGF, placental growth factor; ROS, reactive oxygen species; Tie-2, tunica interna endothelia cell kinase 2; VEGF, vascular endothelial growth factor; VSMCs, vascular smooth muscle cells